American Journal of Epidemiology Vol. 128, No. 2: 389-401
Copyright © 1988 by The Johns Hopkins University School of Hygiene and Public Health
research-article |
MORTALITY AMONG DIABETICS IN A NATIONAL SAMPLE
1Division of Analysis, National Center for Health Statistics Federal Center Building no. 2, Room 227, 3700 East-West Highway, Hyattsville, MD 20782
2Clinical and Genetic Epidemiology Branch, Division of Epidemiology and Clinical Applications National Heart, Lung, and Blood Institute, Bethesda, MD
3National Diabetes Data Group, National Institute of Diabetes Digestive and Kidney Diseases, Bethesda, MD
4Biometry Office, Epidemiology, Demography, and Biometry Program, National Institute on Aging Bethesda, MD
Reprint requests to Dr. Joel C. Kleinman
The authors compare the mortality experience of a national sample of diabetic men and women with their nondiabetic counterparts. The study population consists of respondents from the First National Health and Nutrition Examination Survey (NHANES I), conducted in 19711975, who were traced in 19821984 through the NHANES I Epidemiologic Follow-up Study. Over the nine-year follow-up period, the age-adjusted death rates for diabetic men and women were twice the rates for nondiabetics. About 75% of the excess mortality among diabetic men and 57% among diabetic women was attributable to cardiovascular disease deaths. After adjustment for age, systolic blood pressure, serum cholesterol, body mass index, and smoking, the relative risk of death was 2.3 for diabetic men and 2.0 for diabetic women. The relative risk for diabetics was highest for ischemic heart disease mortality (2.8 for men and 2.5 for women) and lowest for noncardiovascular disease deaths (1.4 for men and 1.1 for women). When subjects who reported having had a heart attack prior to the baseline examination were excluded, the relative risks for ischemic heart disease mortality among diabetics remained substantial (2.4 for men and 2.6 for women). There was little evidence that the relative risk of death for diabetics compared with nondiabetics differed by age or sex, although 95% confidence intervals around these estimates were wide.
cardiovascular diseases; coronary disease; diabetes mellitus; follow-up studies; mortality
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
B. V. Howard, M. J. Roman, R. B. Devereux, J. L. Fleg, J. M. Galloway, J. A. Henderson, Wm. J. Howard, E. T. Lee, M. Mete, B. Poolaw, et al. Effect of Lower Targets for Blood Pressure and LDL Cholesterol on Atherosclerosis in Diabetes: The SANDS Randomized Trial JAMA, April 9, 2008; 299(14): 1678 - 1689. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. M. Okin, R. B. Devereux, K. E. Harris, S. Jern, S. E. Kjeldsen, L. H. Lindholm, B. Dahlof, and for the LIFE Study Investigators In-Treatment Resolution or Absence of Electrocardiographic Left Ventricular Hypertrophy Is Associated With Decreased Incidence of New-Onset Diabetes Mellitus in Hypertensive Patients: The Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) Study Hypertension, November 1, 2007; 50(5): 984 - 990. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. N. McEwen, C. Kim, A. J. Karter, M. N. Haan, D. Ghosh, P. M. Lantz, C. M. Mangione, T. J. Thompson, and W. H. Herman Risk Factors for Mortality Among Patients With Diabetes: The Translating Research Into Action for Diabetes (TRIAD) Study Diabetes Care, July 1, 2007; 30(7): 1736 - 1741. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. M. Okin, R. B. Devereux, E. Gerdts, S. M. Snapinn, K. E. Harris, S. Jern, S. E. Kjeldsen, S. Julius, J. M. Edelman, L. H. Lindholm, et al. Impact of Diabetes Mellitus on Regression of Electrocardiographic Left Ventricular Hypertrophy and the Prediction of Outcome During Antihypertensive Therapy: The Losartan Intervention For Endpoint (LIFE) Reduction in Hypertension Study Circulation, March 28, 2006; 113(12): 1588 - 1596. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. N. McEwen, C. Kim, M. Haan, D. Ghosh, P. M. Lantz, C. M. Mangione, M. M. Safford, D. Marrero, T. J. Thompson, W. H. Herman, et al. Diabetes Reporting as a Cause of Death: Results from the Translating Research Into Action for Diabetes (TRIAD) study Diabetes Care, February 1, 2006; 29(2): 247 - 253. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Huxley, F. Barzi, and M. Woodward Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies BMJ, January 14, 2006; 332(7533): 73 - 78. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A Leiter, D J. Betteridge, A. R Chacra, A. Chait, E. Ferrannini, S. M Haffner, T. Kadowaki, J. Tuomilehto, P. Zimmet, C. B Newman, et al. AUDIT study. Evidence of global undertreatment of dyslipidaemia in patients with type 2 diabetes mellitus The British Journal of Diabetes & Vascular Disease, January 1, 2006; 6(1): 31 - 40. [Abstract] [PDF] |
||||
![]() |
M. Jeffreys, C. Wright, A. 't Mannetje, K. Huang, and N. Pearce Ethnic differences in cause specific mortality among hospitalised patients with diabetes: a linkage study in New Zealand J Epidemiol Community Health, November 1, 2005; 59(11): 961 - 966. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Vijan and R. A. Hayward Pharmacologic Lipid-Lowering Therapy in Type 2 Diabetes Mellitus: Background Paper for the American College of Physicians Ann Intern Med, April 20, 2004; 140(8): 650 - 658. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Mudaliar Intense Management of Diabetes Mellitus: Role of Glucose Control and Antiplatelet Agents J. Clin. Pharmacol., April 1, 2004; 44(4): 414 - 422. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. M. Okin, R. B. Devereux, E. T. Lee, J. M. Galloway, and B. V. Howard Electrocardiographic Repolarization Complexity and Abnormality Predict All-Cause and Cardiovascular Mortality in Diabetes: The Strong Heart Study Diabetes, February 1, 2004; 53(2): 434 - 440. [Abstract] [Full Text] |
||||
![]() |
S. Vijan and R. A. Hayward Treatment of Hypertension in Type 2 Diabetes Mellitus: Blood Pressure Goals, Choice of Agents, and Setting Priorities in Diabetes Care Ann Intern Med, April 1, 2003; 138(7): 593 - 602. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. E. Resnick, K. Jones, G. Ruotolo, A. K. Jain, J. Henderson, W. Lu, and B. V. Howard Insulin Resistance, the Metabolic Syndrome, and Risk of Incident Cardiovascular Disease in Nondiabetic American Indians: The Strong Heart Study Diabetes Care, March 1, 2003; 26(3): 861 - 867. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Kanaya, D. Grady, and E. Barrett-Connor Explaining the Sex Difference in Coronary Heart Disease Mortality Among Patients With Type 2 Diabetes Mellitus: A Meta-analysis Arch Intern Med, August 12, 2002; 162(15): 1737 - 1745. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Singh Diabetes, Heart Rate, and Mortality Journal of Cardiovascular Pharmacology and Therapeutics, June 1, 2002; 7(2): 117 - 129. [Abstract] [PDF] |
||||
![]() |
B. V. Howard, B. L. Rodriguez, P. H. Bennett, M. I. Harris, R. Hamman, L. H. Kuller, T. A. Pearson, and J. Wylie-Rosett Prevention Conference VI: Diabetes and Cardiovascular Disease: Writing Group I: Epidemiology Circulation, May 7, 2002; 105 (18): e132 - e137. [Full Text] [PDF] |
||||
![]() |
DECODE Study Group; on behalf of the European Diab Glucose Tolerance and Cardiovascular Mortality: Comparison of Fasting and 2-Hour Diagnostic Criteria Arch Intern Med, February 12, 2001; 161(3): 397 - 405. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Lotufo, J. M. Gaziano, C. U. Chae, U. A. Ajani, G. Moreno-John, J. E. Buring, and J. E. Manson Diabetes and All-Cause and Coronary Heart Disease Mortality Among US Male Physicians Arch Intern Med, January 22, 2001; 161(2): 242 - 247. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Palmieri, J. N. Bella, D. K. Arnett, J. E. Liu, A. Oberman, M.-Y. Schuck, D. W. Kitzman, P. N. Hopkins, D. Morgan, D. C. Rao, et al. Effect of Type 2 Diabetes Mellitus on Left Ventricular Geometry and Systolic Function in Hypertensive Subjects : Hypertension Genetic Epidemiology Network (HyperGEN) Study Circulation, January 2, 2001; 103(1): 102 - 107. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. B. Devereux, M. J. Roman, M. Paranicas, M. J. O'Grady, E. T. Lee, T. K. Welty, R. R. Fabsitz, D. Robbins, E. R. Rhoades, and B. V. Howard Impact of Diabetes on Cardiac Structure and Function : The Strong Heart Study Circulation, May 16, 2000; 101(19): 2271 - 2276. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. J. Elliott, D. R. Weir, and H. R. Black Cost-effectiveness of the Lower Treatment Goal (of JNC VI) for Diabetic Hypertensive Patients Arch Intern Med, May 8, 2000; 160(9): 1277 - 1283. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Akbari, F. B. Pomposelli Jr, G. W. Gibbons, D. R. Campbell, M. C. Pulling, D. Mydlarz, and F. W. LoGerfo Lower Extremity Revascularization in Diabetes: Late Observations Arch Surg, April 1, 2000; 135(4): 452 - 456. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Klein, B. E. K. Klein, S. E. Moss, and K. J. Cruickshanks Association of Ocular Disease and Mortality in a Diabetic Population Arch Ophthalmol, November 1, 1999; 117(11): 1487 - 1495. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. M. Psaty, C. D. Furberg, L. H. Kuller, D. E. Bild, P. M. Rautaharju, J. F. Polak, E. Bovill, and J. S. Gottdiener Traditional Risk Factors and Subclinical Disease Measures as Predictors of First Myocardial Infarction in Older Adults: The Cardiovascular Health Study Arch Intern Med, June 28, 1999; 159(12): 1339 - 1347. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. D. Kanters, J.-D. Banga, R. P Stolk, and A. Algra Incidence and determinants of mortality and cardiovascular events in diabetes mellitus: a meta-analysis Vascular Medicine, May 1, 1999; 4(2): 67 - 75. [Abstract] [PDF] |
||||
![]() |
J. W SAYER and A. D TIMMIS Investigation of coronary artery disease in diabetes: is screening of asymptomatic patients necessary? Heart, December 1, 1997; 78(6): 525 - 526. [Full Text] [PDF] |
||||
![]() |
G. E. Fraser and D. J. Shavlik Risk Factors for All-Cause and Coronary Heart Disease Mortality in the Oldest-Old: The Adventist Health Study Arch Intern Med, October 27, 1997; 157(19): 2249 - 2258. [Abstract] [PDF] |
||||
![]() |
R. Klein, B. E. K. Klein, and S. E. Moss Is Obesity Related to Microvascular and Macrovascular Complications in Diabetes? The Wisconsin Epidemiologic Study of Diabetic Retinopathy Arch Intern Med, March 24, 1997; 157(6): 650 - 656. [Abstract] [PDF] |
||||
![]() |
N. Chaturvedi, J. Jarrett, N. Morrish, H. Keen, and J. H Fuller Differences in mortality and morbidity in African Caribbean and European people with non-insulin dependent diabetes mellitus: results of 20 year follow up of a London cohort of a multinational study BMJ, October 5, 1996; 313(7061): 848 - 852. [Abstract] [Full Text] |
||||
![]() |
P. H. Frost, B. R. Davis, A. J. Burlando, J. David Curb, G. P. Guthrie Jr, J. L. Isaacsohn, S. Wassertheil-Smoller, A. C. Wilson, and J. Stamler Coronary Heart Disease Risk Factors in Men and Women Aged 60 Years and Older : Findings From the Systolic Hypertension in the Elderly Program Circulation, July 1, 1996; 94(1): 26 - 34. [Abstract] [Full Text] |
||||
![]() |
S. Genuth Exogenous Insulin Administration and Cardiovascular Risk in Non-Insulin-dependent and Insulin-dependent Diabetes Mellitus Ann Intern Med, January 1, 1996; 124(1_Part_2): 104 - 109. [Abstract] [Full Text] |
||||
![]() |
S. E. Moss, R. Klein, B. E. K. Klein, and S. M. Meuer The Association of Glycemia and Cause-Specific Mortality in a Diabetic Population Arch Intern Med, November 14, 1994; 154(21): 2473 - 2479. [Abstract] [PDF] |
||||
![]() |
R. Garg, D. K. Wagener, and J. H. Madans Alcohol Consumption and Risk of Ischemic Heart Disease in Women Arch Intern Med, May 24, 1993; 153(10): 1211 - 1216. [Abstract] [PDF] |
||||
![]() |
F. F. Finucane, J. H. Madans, T. L. Bush, P. H. Wolf, and J. C. Kleinman Decreased Risk of Stroke Among Postmenopausal Hormone Users: Results From a National Cohort Arch Intern Med, January 11, 1993; 153(1): 73 - 79. [Abstract] [PDF] |
||||
![]() |
E. L. Barrett-Connor, B. A. Cohn, D. L. Wingard, and S. L. Edelstein Why Is Diabetes Mellitus a Stronger Risk Factor for Fatal Ischemic Heart Disease in Women Than in Men? The Rancho Bernardo Study JAMA, February 6, 1991; 265(5): 627 - 631. [Abstract] [PDF] |
||||
![]() |
D. M. Huse, G. Oster, A. R. Killen, M. J. Lacey, and G. A. Colditz The Economic Costs of Non--Insulin-Dependent Diabetes Mellitus JAMA, November 17, 1989; 262(19): 2708 - 2713. [Abstract] [PDF] |
||||















